Effect of DPP-4 inhibitor on beta cell protection.
Phase of Trial: Phase III
Latest Information Update: 13 May 2016
At a glance
- Drugs Sitagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 15 Jan 2012 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan.
- 17 Dec 2010 New trial record